...
机译:人组胺H3 sub>受体同源性模型的建立,用于配体对接和基于药效团的筛选
Institute of Pharmaceutical Chemistry Heinrich-Heine-Universität Düsseldorf Universitätsstr. 1 40197 Dusseldorf Germany;
Institute of Pharmaceutical Chemistry Leopold-Franzens-Universität Innsbruck Innrain 52 Innsbruck 6020 Austria;
Department of Pharmaceutical Chemistry Martin-Luther Universität Halle-Wittenberg Wolfgang-Langenbeckstr. 4 06120 Halle/Saale Germany;
Institute of Pharmaceutical Chemistry Leopold-Franzens-Universität Innsbruck Innrain 52 Innsbruck 6020 Austria;
Department of Pharmacology and Toxicology Institute of Pharmacy University of Regensburg 93040 Regensburg Germany;
Department of Pharmacology and Toxicology Institute of Pharmacy University of Regensburg 93040 Regensburg Germany;
Institute of Pharmaceutical Chemistry Biozentrum ZAFES/CMP Johann Wolfgang Goethe-Universität 60438 Frankfurt Germany;
Institute of Pharmaceutical Chemistry Heinrich-Heine-Universität Düsseldorf Universitätsstr. 1 40197 Dusseldorf Germany;
Department of Pharmaceutical Chemistry Martin-Luther Universität Halle-Wittenberg Wolfgang-Langenbeckstr. 4 06120 Halle/Saale Germany;
Histamine; H3 receptor; Docking; Molecular dynamics; GOLD; Catalyst; Pharmacophore; Rhodopsin;
机译:人类组胺H-3受体的同源性模型用于配体对接和基于药效团的筛选
机译:人体过敏药物fexofenadine,组胺的拮抗剂(h
机译:人组胺H4受体的假受体的同源性模型调整和配体筛选
机译:人体整合素alpha_v beta_5:同源性建模和配体对接。用于配体结合选择性的可执行
机译:在计算机上使用定量结构活性关系建模和蛋白质-配体对接的集成方法筛选人类嗜中性粒细胞弹性蛋白酶的新型抑制剂。
机译:人组胺H1受体在人组胺H1受体的分子决定因素:在H1同源性和晶体结构模型中用配体对接和分子动力学研究分析的位点诱变结果
机译:产生人组胺H3受体的同源模型,用于配体对接和基于药效基团的筛选